Detalhe da pesquisa
1.
Management of brain metastases from lung cancer in the era of immunotherapy: a review of the literature.
Future Oncol
; 17(5): 597-609, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33401981
2.
Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.
Anticancer Drugs
; 28(6): 654-659, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28252532
3.
Modified 3-week schedule of gemcitabine plus cisplatin for non-small cell lung cancer treatment.
J BUON
; 22(6): 1395-1403, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29332329
4.
Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.
Future Oncol
; 16(19): 1321-1322, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452225
5.
Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy.
Target Oncol
; 18(1): 129-138, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482151
6.
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?
Semin Oncol
; 50(3-5): 90-101, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673696
7.
Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis.
Joint Bone Spine
; 89(4): 105403, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508288
8.
Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab.
Immunotherapy
; 13(13): 1093-1103, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34190578
9.
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer.
Crit Rev Oncol Hematol
; 162: 103351, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989769
10.
Role of circulating tumor DNA in the detection of sensitizing and resistance to epidermal growth factor receptor mutations in metastatic lung adenocarcinoma.
J BUON
; 25(2): 848-854, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32521877
11.
An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.
Expert Opin Drug Metab Toxicol
; 9(8): 1037-51, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23705788